Hereditary breast cancer: an integrated review of diagnostic testing and management recommendations in Belgium

Read full text Summarise with VIRAT
Authors: Kathleen Claes, Sofie Joris, Liene Bossaerts, Jérôme COUPIER, Damien Féret, Michail Ignatiadis, Katleen Janssens, Natacha Leroi, Edith Sépulchre, Katrien Storm, Daphné 't Kint de Roodenbeke
Cited by: 0
References: 94

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

working group -Cancer predispositionHereditary breast cancer: an integrated review of diagnostic testing and management recommendations in Belgium SUMMARY Hereditary breast cancer is most commonly linked to pathogenic germline variants in BRCA1 and BRCA2 (gBRCAm), and are associated with significant clinical implications.Carriers face elevated lifetime risks of breast, ovarian, prostate, and pancreatic cancers, making timely identification essential for prevention and treatment.Genetic results guide surveillance strategies, risk-reducing surgeries, and reproductive decisions in younger women.They also guide systemic therapy, with poly(ADP-ribose) polymerase inhibitors (PARPi) now standard in high-risk early and metastatic human epidermal growth factor receptor 2 (HER2)-negative gBRCAm breast cancer, as well as other tumour types.In Belgium, the 2023 update of the College of Genetics guidelines expanded testing criteria beyond age and family history to include therapeutic eligibility.Additionally, multigene panel testing has become routine in clinical practice, reflecting a shift toward broader and more inclusive genetic screening.Importantly, germline and tumour testing are increasingly initiated not only by clinical geneticists but also by medical oncologists, facilitating faster access to precision therapies.

Fields of Study & Subjects

BRCA gene mutations in cancer PARP inhibition in cancer therapy Genetic factors in colorectal cancer

Publication details

Journal / source
Open Repository and Bibliography (University of Liège)
Publication date
1 March 2026
Language
EN